Rocket Pharmaceuticals says FDA agrees to 12-patient study for accelerated approval, expects to raise $175M - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
Rocket Pharmaceuticals announced Wednesday that it expects to raise $175 million from a stock sale, a day after the Cranbury, NJ-based biotech said the FDA agreed to its plan to apply for accelerated approval of its Danon disease gene therapy based on a 12-pa…